Invest now

Brooks Laboratories share price

Extreme risk
  • 76%Low risk
  • 76%Moderate risk
  • 76%Balanced risk
  • 76%High risk
  • 76%Extreme risk
  • 59.50(0.29%)
    August 19, 2026 15:15:50 PM IST
    • NSE
    • BSE
  • Vol : 16.26 K (NSE + BSE)
    Last 20 day avg : 25.37 K
Brooks Laboratories is trading 0.29% upper at Rs 59.50 as compared to its last closing price. Brooks Laboratories has been trading in the price range of 59.50 & 59.50. The company posted a net profit of 1.52 Crores in its last quarter.The Mutual Fund holding in Brooks Laboratories was at 9.90% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Brooks Laboratories was at 0.17% in 31 Mar 2026. The FII holding has increased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 19 Aug 2026, 06:19 PM IST

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    2.10
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.07
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.46
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
59.50
Highest
59.50
52 week range
Lowest
36.90
Highest
162.80
Mutual Fund Ownership
View all
Quant Business Cycle Fund Regular Growth
NA
  • Amount Invested (Cr.) 41.80
  • % of AUM 3.14
Brooks Laboratories Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-08-13Quarterly Results
2026-05-29Quarterly Results
2026-02-06Quarterly Results
2025-11-14Quarterly Results
2025-08-13Quarterly Results
About the company Brooks Laboratories
  • IndustryMajor Drugs
  • ISININE650L01011
  • BSE Code533543
  • NSE CodeBROOKS
  • Management Info
Management info for Brooks Laboratories is currently unavailable
Please check back later.
Brooks Laboratories Share Price FAQs

Brooks Laboratories is trading at 59.50 as on Wed Aug 19 2026 09:45:50. This is 0.29% upper as compared to its previous closing price of 59.33.

The market capitalization of Brooks Laboratories is 177.09 Cr as on Wed Aug 19 2026 09:45:50.

The 52 wk high for Brooks Laboratories is 162.80 whereas the 52 wk low is 36.90

Brooks Laboratories can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: %
  • D/E ratio: -

Brooks Laboratories reported a net profit of 24.58 Cr in 2026.

The Mutual Fund Shareholding was 9.90% at the end of 30 Jun 2026.